No definition available.
Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)
C3_BONE_CARTILAGE_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
671 |
6. Filter based on genotype QC (FinnGen only) |
671 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
- Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of bone and articular cartilage
- Malignant neoplasm of bone and articular cartilage of other and unspecified sites
- Malignant neoplasm of bone and articular cartilage of limbs
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 671 | 315 | 356 |
| Unadjusted period prevalence (%) | 0.13 | 0.11 | 0.16 |
| Median age at first event (years) | 55.90 | 55.37 | 56.38 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 289
- Matched controls
- 2888
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
99.9
90
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
108.9
99.7
105
15
H02AB02
ATC
dexamethasone; systemic
88.3
71.7
78
12
JN4BD
NOMESCO Finland
Extensive body CT
27.3
64.2
90
47
L03AA02
ATC
filgrastim; parenteral
749.5
63.3
60
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
56.1
52
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
60.3
53.7
62
13
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
597.8
52.2
50
*
N02AA05
ATC
oxycodone; systemic
10.7
48.4
103
142
9180/3-C40.2
ICD-O-3
Osteosarcoma, NOS, of long bones of lower limb and associated joints
+∞
47.2
44
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
45.0
42
*
C40.21
ICD-10 Finland
Osteosarcoma of the long bones of the lower extremity
+∞
45.0
42
*
A03FA01
ATC
metoclopramide; systemic, rectal
9.8
44.3
99
146
A04AA02
ATC
granisetron; systemic, transdermal
+∞
43.9
41
*
A04AA01
ATC
ondansetron; systemic, rectal
27.5
40.7
56
25
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
39.5
37
*
C40.20
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity without histology
+∞
37.3
35
*
XX3DW
NOMESCO Finland
Time consuming IT work
16.1
36.8
61
47
JN4AD
NOMESCO Finland
Body CT examination
20.3
36.3
55
33
L03AA13
ATC
pegfilgrastim; parenteral
+∞
35.1
33
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
34.0
32
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.0
33.6
145
486
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
15.2
33.6
57
46
C40.22
ICD-10 Finland
Chondrosarcoma of the long bones of the lower extremity
+∞
32.9
31
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
49.8
32.8
39
9
WF002
NOMESCO Finland
Radical radiotherapy
361.7
32.5
32
*
B01AB05
ATC
enoxaparin; parenteral
4.9
31.2
131
419
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
31.2
182
805
NF3AA
NOMESCO Finland
Femur X-ray examination
29.6
30.7
41
16
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
322.6
29.3
29
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
28.6
27
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.6
28.5
126
416
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
27.5
26
*
XW000
NOMESCO Finland
Bone marrow biopsy
15.9
27.4
45
33
N03AX16
ATC
pregabalin; oral
4.6
27.2
116
366
Z51.5
ICD-10 Finland
Palliative care
29.2
26.9
36
14
WW500
NOMESCO Finland
Blood transfusion
24.1
26.9
38
18
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.0
26.6
55
66
JN4CD
NOMESCO Finland
Very extensive body CT
49.4
26.1
31
7
R4110
NOMESCO Finland
Physiotherapy
4.3
26.0
125
439
TPX10
NOMESCO Finland
Implantation of vascular injection port
28.2
26.0
35
14
C40.29
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity other or unspecified histology
+∞
25.4
24
*
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
25.4
24
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
25.4
24
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
24.7
25.0
35
16
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
24.3
23
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
24.3
23
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
24.3
23
*
9220/3-C40.2
ICD-O-3
Chondrosarcoma, NOS, of long bones of lower limb and associated joints
+∞
24.3
23
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
94.9
24.1
26
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.0
24.0
89
238
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.3
23.8
51
65
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
23.2
22
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
23.2
22
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.0
23.0
60
104
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
22.2
21
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
22.2
21
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
30.8
21.4
28
10
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
21.1
20
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
21.1
20
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
21.1
20
*
ZX120
NOMESCO Finland
Intravenous
7.1
20.3
52
87
B01AB10
ATC
tinzaparin; parenteral
9.2
20.1
43
54
NG4AA
NOMESCO Finland
Lower leg X-ray examination
12.7
20.1
36
32
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
20.0
19
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
21.3
20.0
29
15
GD1AD
NOMESCO Finland
Thorax CT examination
11.3
19.6
37
37
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
19.0
18
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
19.0
18
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
19.0
18
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
+∞
19.0
18
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.7
18.7
69
179
WX402
NOMESCO Finland
General anaesthesia
4.4
18.4
74
209
17071
ICD-8 Finland
Malignant neoplasm of bone, Lower limb, long bones
+∞
17.9
17
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
13.8
17.6
30
24
WZC30
NOMESCO Finland
Teaching
4.8
17.1
61
152
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
13.9
17.1
29
23
153
Kela drug reimbursment
Lenalidomid
+∞
16.8
16
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
+∞
16.8
16
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.9
16.8
39
56
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
179.9
16.7
17
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
63.7
15.9
18
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
6.0
15.8
45
86
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
15.8
15
*
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
+∞
15.8
15
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
15.8
15
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
15.8
15
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
+∞
15.8
15
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
6.7
15.0
39
66
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
84.5
14.7
16
*
C40.02
ICD-10 Finland
Chondrosarcoma of the scapula and long bones of the upper extremity
+∞
14.7
14
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
14.7
14
*
9220/3-C41.3
ICD-O-3
Chondrosarcoma, NOS, of rib, sternum, clavicle and associated joints
+∞
14.7
14
*
C41.49
ICD-10 Finland
Malignant tumor of the pelvic bones, sacrum and coccyx other or unspecified histology
+∞
14.7
14
*
L04AX04
ATC
lenalidomide; oral
+∞
14.7
14
*
NGB30
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part - connected prosthesis
38.2
14.6
18
5
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
157.6
14.6
15
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
13.9
122
604
R50.9
ICD-10 Finland
Fever, unspecified
3.8
13.8
63
196
9101
FHL
Bone biopsy
+∞
13.6
13
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
13.6
13
*
A04AD12
ATC
aprepitant; systemic
+∞
13.6
13
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
13.6
13
*
AA1AA
NOMESCO Finland
Head X-ray examination
146.6
13.6
14
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
146.6
13.6
14
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
9.7
13.0
26
29
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
52.5
13.0
15
*
N02BE01
ATC
paracetamol; systemic, rectal
3.3
12.9
253
1957
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
12.6
12
*
329
Kela drug reimbursment
Lenalidomide
+∞
12.6
12
*
9370/3-C41.4
ICD-O-3
Chordoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
12.6
12
*
C41.42
ICD-10 Finland
Chondrosarcoma of the pelvic bones, sacrum and coccyx
+∞
12.6
12
*
C40.00
ICD-10 Finland
Malignant tumor of the scapula and the long bones of the upper extremity without histology
+∞
12.6
12
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
6.0
12.6
35
65
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
12.4
12.5
22
19
GAE06
NOMESCO Finland
Excision of lesion of chest wall
135.6
12.5
13
*
N02AX02
ATC
tramadol; systemic, rectal
2.5
12.3
138
770
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
11.9
95
437
ZX112
NOMESCO Finland
Subcutaneous
20.0
11.7
17
9
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
67.8
11.7
13
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.0
11.6
32
59
C41.32
ICD-10 Finland
Chondrosarcoma of the ribs, sternum and clavicle
+∞
11.5
11
*
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
+∞
11.5
11
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
11.5
11
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
11.5
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
11.5
11
*
TPX15
NOMESCO Finland
Removal of vascular injection port
124.7
11.5
12
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.1
11.4
45
123
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.6
11.3
53
168
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
22.5
10.8
15
7
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
5.1
10.7
34
74
ZXE40
NOMESCO Finland
More than seven and less than nine hours
9.7
10.7
21
23
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.6
10.5
24
34
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
10.5
127
721
C41.40
ICD-10 Finland
Pelvic bones, sacrum and coccyx
+∞
10.5
10
*
9220/3-C40.0
ICD-O-3
Chondrosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
10.5
10
*
C40.01
ICD-10 Finland
Osteosarcoma of the scapula and the long bones of the upper extremity
+∞
10.5
10
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
10.1
10.4
20
21
ZXD05
NOMESCO Finland
Urgent procedure
2.5
10.3
106
552
A02BC02
ATC
pantoprazole; systemic
2.3
10.3
184
1252
ZXE00
NOMESCO Finland
One hour or less
2.3
10.2
130
755
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
41.6
10.0
12
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.8
10.0
43
127
JN6AD
NOMESCO Finland
CT of torso and neck
27.1
9.9
13
5
PJA12
NOMESCO Finland
Sentinel node biopsy
56.9
9.7
11
*
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
56.9
9.7
11
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
56.9
9.7
11
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.5
9.7
34
83
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
9.5
70
301
1707A
ICD-9 Finland
Malignant neoplasm of bone and articular cartilage, Long bones of lower limb[ALARAAJAN PITKIEN LUIDEN SYÖPÄ,OSTEOSARCOMA]
+∞
9.4
9
*
9731/3-C41.3
ICD-O-3
Plasmacytoma, NOS, of rib, sternum, clavicle and associated joints
+∞
9.4
9
*
115
Kela drug reimbursment
Breast cancer
+∞
9.4
9
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
9.4
9
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
9.4
9
*
9220/3-C41.4
ICD-O-3
Chondrosarcoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
9.4
9
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.4
9
*
A79
ICPC
Malignancy NOS
+∞
9.4
9
*
C41.22
ICD-10 Finland
Chondrosarcoma of the spine
+∞
9.4
9
*
HA1AA
NOMESCO Finland
X-ray mammography
10.0
9.4
18
19
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.2
9.3
20
26
J01MA12
ATC
levofloxacin; systemic
2.8
9.1
65
275
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
38.0
9.1
11
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
24.9
9.0
12
5
B01AB04
ATC
dalteparin; parenteral
6.5
8.8
22
36
L28
ICPC
Limited function/disability (L)
2.8
8.8
60
246
WX002
NOMESCO Finland
Sedation and analgesia
2.6
8.8
71
322
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
8.8
48
169
NB6AA
NOMESCO Finland
Humerus X-ray examination
12.1
8.7
15
13
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.6
8.6
39
120
NFB60
NOMESCO Finland
Demanding prosthetic replacement of hip
28.5
8.5
11
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
28.5
8.5
11
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.9
8.5
35
99
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.3
8.5
31
79
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
92.6
8.5
9
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
92.6
8.5
9
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
8.4
80
395
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
8.4
59
247
J05AB01
ATC
aciclovir; systemic
2.6
8.4
69
316
C40.11
ICD-10 Finland
Osteosarcoma of the short bones of the upper extremity
+∞
8.4
8
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
8.4
8
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
8.4
8
*
GDB10
NOMESCO Finland
Wedge resection of lung
+∞
8.4
8
*
9731/3-C41.2
ICD-O-3
Plasmacytoma, NOS, of vertebral column
+∞
8.4
8
*
C41.41
ICD-10 Finland
Osteosarcoma of the pelvic bones, sacrum and coccyx
+∞
8.4
8
*
WW402
NOMESCO Finland
Leucoferesis
+∞
8.4
8
*
NFA20
NOMESCO Finland
Exploration of hip joint or femur
+∞
8.4
8
*
9180/3-C40.0
ICD-O-3
Osteosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
8.4
8
*
NF3AD
NOMESCO Finland
Femur CT
+∞
8.4
8
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
8.4
8
*
NEA20
NOMESCO Finland
Exploration of soft tissue of pelvis,v
+∞
8.4
8
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
8.4
8
*
C40.91
ICD-10 Finland
Osteosarcoma in unspecified locations in the bones and articular cartilage of the extremities
+∞
8.4
8
*
C41.82
ICD-10 Finland
Overall chondrosarcoma in bone and articular cartilage
+∞
8.4
8
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
8.4
8
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.5
8.2
17
21
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.0
8.2
32
87
NF1AA
NOMESCO Finland
Hip X-ray examination
3.8
8.1
34
98
2392A
ICD-9 Finland
Neoplasm of unspecified nature, Bone, soft tissue and skin
34.4
8.1
10
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.2
8.0
30
78
R52.0
ICD-10 Finland
Acute pain
6.4
8.0
20
33
ZXA05
NOMESCO Finland
Left side
2.3
8.0
87
459
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.4
7.9
28
69
NG1AD
NOMESCO Finland
Knee CT examination
11.2
7.9
14
13
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
11.2
7.9
14
13
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.2
7.8
41
142
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
12.3
7.7
13
11
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
10.4
7.6
14
14
ZXA00
NOMESCO Finland
Right side
2.2
7.5
88
478
SPAT1153
SPAT
Removal of sutures
2.2
7.5
96
541
J05AB11
ATC
valaciclovir; oral
3.0
7.5
44
165
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
82.1
7.5
8
*
NER20
NOMESCO Finland
Incomplete excision of soft tissue tumour of pelvis
82.1
7.5
8
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
+∞
7.3
7
*
C40.10
ICD-10 Finland
Malignant tumor of the upper limb's short bones without histology
+∞
7.3
7
*
GAE23
NOMESCO Finland
Resection of chest wall and prosthetic repair
+∞
7.3
7
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.3
7
*
9680/3-C41.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
7.3
7
*
C41.3
ICD-10 Finland
Malignant neoplasm: Ribs, sternum and clavicle
+∞
7.3
7
*
WW409
NOMESCO Finland
Other aferesis
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
NK6AT
NOMESCO Finland
Bone biopsy with ultrasound guidance
+∞
7.3
7
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
16.3
7.3
11
7
9102
FHL
Trepanation or removal of the local bone process
20.6
7.2
10
5
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.0
7.1
27
72
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.9
7.1
22
48
M05BX04
ATC
denosumab; parenteral
6.1
7.0
18
31
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
7.0
34
111
S18
ICPC
Laceration/cut
2.0
7.0
125
803
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.8
6.7
21
46
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
6.4
6.6
16
26
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
71.3
6.4
7
*
HAC20
NOMESCO Finland
Total mastectomy
71.3
6.4
7
*
ZX121
NOMESCO Finland
Central venous catheter
71.3
6.4
7
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
71.3
6.4
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
71.3
6.4
7
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
18.5
6.3
9
5
H02AB09
ATC
hydrocortisone; systemic
7.3
6.3
14
20
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
+∞
6.3
6
*
C41.00
ICD-10 Finland
Malignant tumor of the skull or facial bone without histology
+∞
6.3
6
*
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
+∞
6.3
6
*
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
C41.09
ICD-10 Finland
Malignant tumor of the skull or facial bones other or unspecified histology
+∞
6.3
6
*
C40.12
ICD-10 Finland
Chondrosarcoma of the short bones of the upper extremity
+∞
6.3
6
*
C40.23
ICD-10 Finland
Ewing's sarcoma in the long bones of the lower extremity
+∞
6.3
6
*
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
+∞
6.3
6
*
NFQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of hip or femur
+∞
6.3
6
*
NGR40
NOMESCO Finland
Extensive excision of tumor of knee or lower leg with repair
+∞
6.3
6
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
GDA20
NOMESCO Finland
Excision of lesion of lung
+∞
6.3
6
*
NB4AA
NOMESCO Finland
Scapula X-ray examination
+∞
6.3
6
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
6.3
6
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
6.3
6
*
9220/3-C41.0
ICD-O-3
Chondrosarcoma, NOS, of bones of skull and face and associated joints
+∞
6.3
6
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
6.3
6
*
C40.93
ICD-10 Finland
Malignant tumor in unspecified locations in the bones and articular cartilage of the extremities
+∞
6.3
6
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
12.9
6.1
10
8
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
8.9
6.1
12
14
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
5.4
6.1
17
33
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
6.1
62
314
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
6.3
6.1
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
154
137
14.29
153.24
1.6
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
212
704
3.94
55.14
9.1
3.3
mmol/l
0.8
0.8
1.79
200
652
(40760888) Immunoglobulin light chains.free panel - Serum
69
89
8.53
51.08
9.7
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
79
123
7.15
49.64
9.7
1.3
ratio
7.6
1.1
—
6
13
(40768804) Tissue Pathology biopsy report
329
1537
3.24
48.83
2.9
1.7
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
79
127
6.92
48.15
9.9
1.3
mg/l
35.0
47.9
1.08
65
106
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
79
128
6.86
47.78
9.8
1.3
mg/l
44.3
33.9
0.24
65
108
(21494890) Protein electrophoresis panel - 24 hour Urine
44
35
13.38
45.60
2.9
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
300
1397
3.08
43.65
4.5
2.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
424
2401
3.08
43.11
13.6
4.0
umol/l
10.4
12.0
0.90
404
2257
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
394
2190
2.94
40.58
14.6
6.0
mmol/l
1.2
1.2
0.74
365
1959
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
418
2429
2.91
39.05
17.6
6.2
mmol/l
1.2
1.2
1.56
355
2082
(3023368) Bacteria identified in Blood by Culture
275
1283
2.94
38.96
6.8
3.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
375
2065
2.85
38.72
7.8
4.0
g/l
34.2
35.9
6.77
353
1901
(3013650) Neutrophils [#/volume] in Blood by Automated count
453
2759
2.98
38.53
21.7
6.4
e9/l
4.1
4.3
0.64
415
2395
(3003458) Phosphate [Moles/volume] in Serum or Plasma
178
670
3.25
36.50
9.6
5.7
mmol/l
1.1
1.1
0.21
167
611
(3004588) Protein electrophoresis panel - Serum or Plasma
111
307
4.13
36.23
7.9
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
306
1563
2.76
35.81
7.7
2.1
mmol/l
2.3
2.4
0.40
282
1301
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
98
250
4.42
35.57
4.7
1.6
ug/l
36.7
4.0
0.68
72
188
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
375
2138
2.71
35.01
6.4
3.7
—
—
—
0
0
(3002256) Pathology report gross observation
119
357
3.84
34.59
1.3
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
236
1072
2.85
34.38
4.5
2.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
249
1200
2.71
31.94
6.6
3.6
%
88.3
87.8
0.12
244
1165
(3027801) Oxygen [Partial pressure] in Arterial blood
150
549
3.23
31.85
9.7
8.4
kpa
14.5
11.8
5.64
145
528
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
150
549
3.23
31.85
9.7
8.4
kpa
5.3
5.1
0.96
145
527
(3019198) Lymphocytes [#/volume] in Blood
410
2543
2.57
30.67
9.2
5.4
e9/l
1.6
1.9
9.42
370
2231
(3003396) Base excess in Arterial blood by calculation
148
551
3.16
30.43
9.8
8.4
mmol/l
1.3
1.4
0.09
118
427
(3001604) Monocytes [#/volume] in Blood
401
2480
2.53
29.89
9.2
5.4
e9/l
0.6
0.6
0.82
362
2142
(3047189) Immunofixation for 24 hour Urine
22
10
22.71
29.66
2.3
1.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
401
2494
2.51
29.32
9.2
5.4
e9/l
0.0
0.0
3.25
361
2159
(3037756) Immunofixation for Serum or Plasma
46
70
6.98
29.27
4.3
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
31
29
11.16
28.85
3.0
2.2
%
13.6
10.8
0.32
16
18
(3032080) INR in Blood by Coagulation assay
342
1996
2.46
28.50
9.4
9.7
inr
1.2
1.3
4.16
102
553
(3011412) CD3 cells [#/volume] in Blood
34
37
9.63
28.48
3.0
2.0
e9/l
0.9
1.4
0.94
23
20
(3013115) Eosinophils [#/volume] in Blood
407
2577
2.47
28.18
10.3
5.6
e9/l
0.2
0.2
0.67
371
2262
(3022096) Basophils/100 leukocytes in Blood
369
2251
2.42
27.55
9.5
5.6
%
0.6
0.7
2.34
356
2093
(3017181) Myelocytes/100 leukocytes in Blood
109
358
3.44
27.34
5.2
4.0
%
1.6
0.8
2.06
51
72
(3002179) Metamyelocytes/100 leukocytes in Blood
103
327
3.54
27.23
4.7
4.1
%
0.7
0.4
0.76
43
55
(3006504) Eosinophils/100 leukocytes in Blood
375
2324
2.39
26.73
9.5
5.6
%
2.8
3.0
0.79
363
2154
(3019069) Monocytes/100 leukocytes in Blood
376
2333
2.39
26.73
9.8
5.8
%
9.1
8.6
1.93
364
2177
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
32
7
47.86
26.70
1.2
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
28
26
11.19
26.15
3.3
2.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
380
2388
2.36
25.96
9.6
5.6
%
24.8
28.2
6.85
366
2222
(42870588) Differential panel, method unspecified - Blood
291
1638
2.37
25.57
10.0
5.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
22
14
16.21
25.49
1.1
1.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
375
2363
2.33
25.19
9.2
5.5
%
59.2
56.9
2.83
362
2207
(3018418) pH of Serum or Plasma
259
1406
2.37
24.51
8.8
3.0
ph
7.4
7.4
0.15
70
211
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
23
0
+∞
24.10
25.7
0.0
umol/l
0.3
—
—
23
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
41
68
6.36
24.01
1.7
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
101
343
3.29
23.88
5.4
4.1
%
0.2
0.1
1.40
47
64
(3042936) Bacteria identified in Isolate by Culture
159
697
2.68
23.71
2.4
2.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
516
3794
2.56
23.52
15.7
5.3
u/l
90.1
76.7
4.12
496
3498
(3013826) Glucose [Moles/volume] in Serum or Plasma
435
2981
2.31
23.10
9.9
4.5
mmol/l
6.6
6.7
0.38
419
2780
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
47
93
5.36
22.92
1.9
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
48
97
5.25
22.87
1.7
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
54
121
4.77
22.83
1.7
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
221
1163
2.34
22.04
17.0
4.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
48
102
4.99
21.59
1.7
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
164
774
2.48
20.72
4.3
2.0
s
29.0
30.0
1.61
156
746
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
40
75
5.61
20.66
3.6
5.9
iu/ml
346.7
644.9
—
7
9
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
167
801
2.44
20.33
2.4
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
92
327
3.10
20.04
5.6
4.2
%
0.0
1.7
0.54
42
56
(3028026) IgM [Mass/volume] in Serum or Plasma
84
283
3.25
20.01
3.4
1.3
g/l
1.0
1.1
0.29
79
264
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
179
893
2.37
19.91
5.4
2.1
mmol/l
2.5
2.4
1.70
161
763
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
33
56
6.15
18.86
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
87
313
3.04
18.51
1.5
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
120
519
2.60
18.03
1.7
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
34
63
5.63
17.77
1.7
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
53
143
3.94
17.61
6.0
3.5
u/ml
0.3
0.3
0.11
27
83
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
284
1779
2.03
17.32
4.1
3.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
42
96
4.60
17.31
2.4
2.2
u/ml
22.9
81.8
0.40
33
76
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
110
471
2.60
16.81
4.7
2.8
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
15
10
15.32
16.80
1.6
2.4
%
6.2
5.9
—
15
10
(21494814) CD8 cells/100 lymphocytes in Specimen
15
10
15.32
16.80
1.5
2.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
128
591
2.44
16.66
2.0
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
26
40
6.72
16.30
4.0
4.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
23
31
7.65
16.19
3.6
1.7
e6/l
523.2
535.9
0.04
17
24
(3010503) CD19 cells [#/volume] in Blood
18
18
10.25
15.87
1.7
1.8
e9/l
0.1
0.2
1.35
18
18
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
45
6.21
15.69
1.4
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
229
1370
2.02
15.51
3.5
3.0
e6/l
0.6
0.4
0.24
173
1016
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
22
30
7.55
15.33
3.7
1.7
e9/l
0.1
0.2
1.22
17
24
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
70
249
3.02
15.13
11.0
13.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
54
164
3.49
15.10
1.9
1.7
ug/l
1.7
2.2
0.13
45
146
(3045142) Bone marrow Pathology biopsy report
23
34
6.97
14.94
1.3
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
21
28
7.71
14.91
3.0
1.6
e6/l
603.0
1190.7
—
6
11
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51
152
3.55
14.67
6.3
1.3
g/l
2.2
0.4
0.86
42
134
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
183
3.31
14.61
6.9
1.3
g/l
7.5
7.5
0.04
38
138
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
183
3.31
14.61
6.9
1.3
g/l
3.5
3.7
0.56
33
131
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
183
3.31
14.61
6.9
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
120
573
2.33
14.36
2.2
1.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
26
46
5.84
14.24
2.9
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
85
347
2.66
14.21
10.4
2.6
mmol/l
1.2
1.2
0.20
80
287
(3002582) Erythrocytes [#/volume] in Urine
240
1502
1.93
13.99
3.9
3.1
e6/l
45.6
99.8
0.63
189
1146
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
119
574
2.30
13.88
2.2
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
99
443
2.45
13.67
16.7
9.0
—
—
—
0
0
(3026782) Osmolality of Urine
171
968
2.03
13.21
4.1
2.6
mosm/kgh2o
543.9
560.1
0.45
153
805
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
28
57
5.08
13.21
1.4
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
216
1329
1.92
13.09
3.5
3.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
77
314
2.64
12.88
1.8
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
124
627
2.20
12.85
1.7
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
79
4.34
12.84
1.4
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
214
1321
1.91
12.79
3.9
2.4
umol/l
4378.4
8369.6
0.78
195
1136
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
44
132
3.50
12.53
5.2
3.2
g/l
3.7
3.6
0.24
44
126
(3026008) Bacteria identified in Urine by Culture
229
1455
1.87
12.46
3.7
3.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
172
3.13
12.06
7.3
1.3
g/l
3.1
3.1
0.02
33
133
(3031040) Bacteria [#/volume] in Urine by Automated count
424
3269
1.81
11.93
5.3
4.3
e6/l
9.5
2512.1
—
6
48
(3021589) Normoblasts [#/volume] in Blood
318
2259
1.77
11.81
19.4
7.8
e9/l
0.0
0.0
0.75
268
1835
(3023520) Reticulocytes [#/volume] in Blood
93
432
2.34
11.76
4.9
2.4
e9/l
77.8
69.3
0.83
76
335
(3000850) Epithelial cells [#/volume] in Urine
172
1017
1.93
11.54
3.2
2.4
e6/l
6.3
5.2
0.47
155
888
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
166
3.11
11.50
8.1
1.3
g/l
9.1
10.8
2.26
38
142
(3027945) Reticulocytes/100 erythrocytes in Blood
115
590
2.15
11.42
5.1
2.5
%
2.1
1.7
0.97
108
526
(3018095) Leukocytes [#/volume] in Urine
258
1745
1.78
11.18
5.0
3.6
e6/l
91.8
100.2
0.08
199
1230
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
28
66
4.38
11.11
1.4
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
73
316
2.47
10.77
4.4
5.8
—
—
—
0
0
(44806118)
24
52
4.75
10.55
1.6
1.4
—
—
—
0
0
(44790047)
24
52
4.75
10.55
1.6
1.4
—
—
—
0
0
(44790048)
24
52
4.75
10.55
1.6
1.4
—
—
—
0
0
(44790049)
24
52
4.75
10.55
1.6
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
105
537
2.13
10.47
3.9
2.6
umol/l
5.0
7.6
2.58
93
465
(3000060) B lymphocytes [#/volume] in Blood
13
15
8.82
10.26
5.0
2.4
e6/l
87.5
478.6
—
8
7
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
62
4.32
10.18
1.2
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
114
623
2.00
9.47
3.1
2.5
%
22.4
23.9
0.47
101
530
(3042631) Mycobacterium sp identified in Specimen
22
49
4.61
9.36
2.2
2.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
42
148
2.96
9.23
2.7
3.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
50
4.52
9.14
1.6
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
131
761
1.90
9.08
3.2
2.4
umol/l
12.3
13.5
1.08
123
693
(3003694) ABO and Rh group [Type] in Blood
190
1238
1.75
9.02
1.5
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
43
4.76
8.87
1.7
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
16
28
5.83
8.84
3.3
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
65
3.96
8.76
1.2
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
119
678
1.92
8.72
3.3
2.4
g/l
2.3
2.3
0.49
113
628
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
40
4.86
8.63
1.4
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
76
369
2.19
8.60
5.5
5.4
ph
7.4
7.4
2.96
11
35
(3009214) Lutropin [Units/volume] in Serum or Plasma
37
127
3.03
8.52
1.9
1.7
u/l
10.7
6.6
1.02
26
110
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
30
91
3.40
8.44
4.3
3.2
%
62.9
57.6
1.31
30
91
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
65
298
2.31
8.43
2.1
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
29
87
3.44
8.30
4.5
3.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
73
357
2.17
8.11
5.5
5.4
mmol/l
1.9
1.8
0.07
68
264
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
7
17.43
8.10
1.8
3.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
26
75
3.57
7.89
1.3
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
165
1069
1.72
7.86
7.8
4.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
32
5.10
7.69
1.3
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
28
87
3.31
7.60
3.0
2.5
%
15.3
16.7
0.86
19
47
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
64
306
2.21
7.52
2.1
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
222
1572
1.62
7.45
5.6
2.7
u/l
35.7
32.4
0.59
216
1493
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
26
5.48
7.27
1.4
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
29
95
3.15
7.24
1.4
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
130
805
1.76
7.22
3.5
2.8
e6/l
2.7
2.1
0.33
71
424
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
90
3.20
7.21
3.8
2.9
e9/l
4.5
4.3
0.13
28
90
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
136
863
1.72
6.91
2.8
2.7
e6/l
1.0
1.0
0.04
75
480
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
17
6.56
6.79
1.5
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
17
6.56
6.79
1.5
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
17
40
4.33
6.78
1.1
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
32
4.77
6.71
2.0
3.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
34
128
2.74
6.67
1.4
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
126
792
1.73
6.60
1.7
1.8
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
13
25
5.28
6.51
2.5
2.5
%
37.3
44.7
—
5
10
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
73
389
1.98
6.46
2.7
2.1
ml/min/173m2
72.0
67.9
0.35
36
161
(3028626) Oxygen [Partial pressure] in Capillary blood
40
167
2.48
6.40
4.7
6.3
kpa
8.3
8.8
0.80
40
152
(3037467) Urinalysis macro (dipstick) panel - Urine
420
3507
1.53
6.40
5.2
4.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
36
145
2.57
6.21
6.8
1.2
g/l
39.3
37.6
1.45
30
122
(3012501) Base excess in Blood by calculation
25
85
3.02
5.90
5.5
3.5
mmol/l
2.0
2.6
0.74
15
53
(40768793) Breast Pathology biopsy report
15
36
4.24
5.85
1.4
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
45
3.85
5.84
1.6
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
26
92
2.90
5.73
2.5
2.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
17
5.96
5.64
1.0
1.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
209
1539
1.52
5.63
3.0
2.3
u/l
50.4
56.9
2.09
196
1422
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
260
2004
1.49
5.61
4.4
3.7
ng/l
26.0
41.9
2.59
206
1408
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
155
1071
1.58
5.55
3.1
1.7
mg/l
2.1
1.1
0.84
123
808
(3013707) Erythrocyte sedimentation rate by Westergren method
447
3842
1.49
5.47
5.3
4.1
mm/h
16.7
11.6
5.84
424
3516
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
15
38
4.01
5.46
2.1
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
15
38
4.01
5.46
2.1
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
15
38
4.01
5.46
2.1
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
33
137
2.48
5.38
5.1
2.8
%
184.0
182.4
0.04
33
130
(40768806) Pleura Pathology biopsy report
13
30
4.40
5.31
1.2
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
85
2.89
5.30
1.7
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
78
455
1.81
5.26
16.6
3.6
kpa
4.5
4.6
0.24
78
438
(3000494) Fungus identified in Specimen by Culture
95
589
1.71
5.19
1.5
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
177
1279
1.52
5.15
2.2
2.3
mg/l
3.1
2.9
0.34
153
1078
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
9
10.12
5.04
2.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
11
23
4.85
5.03
6.9
1.0
u/ml
33.3
34.4
—
5
5
(3045788) Cell count panel - Pleural fluid
14
36
3.95
5.01
1.3
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
492
4346
1.50
4.97
35.2
14.6
%
14.1
13.6
10.06
484
4252
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
207
1558
1.48
4.91
3.8
3.1
ng/l
1462.7
1521.8
0.06
182
1320
(3036603) Volume of Urine
12
28
4.35
4.84
2.4
1.4
ml
1706.0
1566.2
—
5
5
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
570
5210
1.62
4.82
30.4
12.2
mg/l
28.7
23.6
2.98
517
3966
(3029937) Albumin [Presence] in Urine by Test strip
180
1329
1.48
4.67
5.5
3.6
estimate
0.0
0.0
0.50
73
412
(3021447) Carbon dioxide [Partial pressure] in Venous blood
86
535
1.70
4.64
17.1
4.0
kpa
5.9
5.8
0.27
86
518
(3035350) Ketones [Presence] in Urine by Test strip
306
2496
1.42
4.64
4.8
3.5
estimate
0.0
0.0
0.00
76
423
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
11
8.27
4.57
1.1
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
305
2493
1.41
4.54
6.4
4.8
estimate
0.0
0.0
0.50
75
420
(40768800) Prostate Pathology biopsy report
10
21
4.82
4.54
1.6
1.1
—
—
—
0
0
(3020891) Body temperature
41
202
2.10
4.53
6.9
4.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
8
8
10.10
4.53
1.1
1.0
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
8
8
10.10
4.53
1.4
4.0
%
165.0
125.4
—
8
8
(3003181) Sodium [Moles/volume] in Urine
22
82
2.74
4.46
1.9
1.6
mmol/l
53.9
66.2
0.66
16
70
(40761536) Microorganisms panel - Urine sediment
69
409
1.77
4.42
6.0
3.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
35
3.77
4.38
1.1
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
28
119
2.41
4.38
1.7
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
50
3.25
4.36
1.4
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
306
2526
1.39
4.20
4.9
3.5
estimate
0.0
0.0
0.00
75
412
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
13
7.00
4.17
1.4
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
13
7.00
4.17
2.2
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
13
7.00
4.17
2.2
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
13
7.00
4.17
2.2
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
13
7.00
4.17
1.4
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
419
3646
1.40
4.17
4.1
3.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
57
3.03
4.15
1.4
1.2
—
—
—
0
0
(3019225) pH of Specimen
75
464
1.69
4.14
10.8
4.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
484
5289
0.70
4.12
4.5
5.0
mmol/l
2.7
2.7
0.71
429
4857
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
244
1944
1.40
4.11
5.3
3.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
28
123
2.33
4.09
24.6
3.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
27
117
2.36
4.06
1.7
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
27
117
2.36
4.06
1.7
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
83
531
1.64
4.04
17.6
4.0
mmol/l
2.2
1.9
0.43
73
428
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
473
5185
0.70
4.04
4.3
4.5
mmol/l
4.5
4.6
0.74
426
4789
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
43
3.30
3.92
2.8
2.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
16
54
3.01
3.87
1.9
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
11
7.35
3.87
1.1
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
470
5144
0.71
3.81
4.2
4.5
mmol/l
1.4
1.4
0.70
420
4725
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
66
2.77
3.78
1.2
1.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
68
422
1.68
3.72
4.6
4.3
ng/l
114.7
84.1
0.94
63
372
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
169
2.07
3.71
2.3
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
36
183
2.02
3.70
2.8
1.7
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
9
7.84
3.56
2.3
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
9
7.84
3.56
2.0
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
139
1025
1.45
3.55
2.7
1.3
g/l
2.4
2.5
0.06
108
616
(3022313) Gas panel - Capillary blood
50
289
1.79
3.52
6.3
5.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
41
3.21
3.51
1.2
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
13
6.21
3.51
7.3
2.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
46
261
1.82
3.44
4.0
2.4
e6/l
0.5
0.2
0.51
46
253
(3035880) pH of Pleural fluid
9
18
5.05
3.38
1.2
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
580
5426
1.51
3.31
35.2
14.8
mmol/l
139.1
139.8
7.06
568
5272
(3025941) Bacteria identified in Stool by Culture
46
265
1.79
3.29
1.3
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
19
4.79
3.24
2.2
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
19
4.79
3.24
2.2
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
19
4.79
3.24
2.2
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
19
4.79
3.24
2.2
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
11
6.42
3.19
1.4
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
11
6.42
3.19
1.4
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
94
655
1.51
3.18
10.5
6.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
580
5439
1.49
3.13
35.5
14.9
mmol/l
4.0
4.0
2.12
567
5271
(3011648) Oxygen content in Venous blood
14
50
2.84
3.10
46.4
2.8
%
9.0
11.0
1.03
14
50
(3044941) Cell count panel - Synovial fluid
18
74
2.47
3.07
1.6
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
34
3.27
3.07
1.0
1.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
35
190
1.89
3.03
3.9
3.7
mmol/l
1.2
1.4
0.57
35
183
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
18
75
2.44
2.99
3.8
2.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
32
566
0.54
2.93
1.7
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
455
4946
0.75
2.93
3.9
4.0
mmol/l
1.3
1.3
0.05
409
4518
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
37
207
1.83
2.93
2.2
1.6
g/l
1.3
1.5
0.74
27
181
(3023323) Follitropin [Units/volume] in Serum or Plasma
29
151
1.96
2.84
2.2
1.6
iu/l
19.4
24.3
0.37
23
130
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
249
2089
1.31
2.76
2.4
2.4
nmol/l
78.9
77.2
0.40
228
1845
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
6
8.38
2.75
1.0
1.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
43
257
1.72
2.75
19.4
2.8
%
0.7
0.7
0.40
43
250
(3017732) Neutrophils [#/volume] in Blood
52
328
1.63
2.72
3.3
2.6
e9/l
3.7
4.2
0.74
43
256
(3004119) Hemoglobin [Mass/volume] in Venous blood
54
344
1.62
2.72
17.4
3.1
g/l
119.9
130.2
3.65
54
338
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
448
4863
0.76
2.70
5.9
6.0
mmol/mol
39.8
40.2
0.30
407
4503
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
19
4.25
2.68
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
19
4.25
2.68
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
38
2.93
2.59
1.4
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
38
2.93
2.59
1.2
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
25
3.63
2.58
1.0
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
11
5.49
2.55
1.0
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
520
4833
1.34
2.54
26.1
11.0
ml/min/173m2
83.8
80.3
2.59
459
3877
(3000475) Leukocytes [#/volume] in Synovial fluid
25
130
1.96
2.48
1.5
1.7
e6/l
11932.4
15073.0
0.21
14
100
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
21
3.84
2.47
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
20
96
2.12
2.45
1.5
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
34
2.97
2.42
4.3
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
12
5.03
2.40
1.7
1.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
15
64
2.37
2.40
1.3
1.6
%
71.9
64.2
—
9
49
(3014271) Vancomycin [Susceptibility]
9
27
3.36
2.40
2.3
2.8
—
—
—
0
0
(3000012) Reticulocyte production index
9
27
3.36
2.40
1.1
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
13
52
2.53
2.37
3.5
1.8
%
86.1
91.4
0.57
13
52
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
22
3.67
2.37
1.3
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
63
431
1.51
2.36
4.5
3.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
167
1353
1.31
2.34
4.9
3.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
65
449
1.50
2.33
2.3
1.9
u/l
38.9
31.3
0.58
50
370
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
41
2.71
2.28
2.4
2.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
11
41
2.71
2.28
1.2
1.4
%
21.0
30.9
—
5
29
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
47
2.58
2.28
1.8
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
13
4.65
2.27
4.2
1.2
nmol/l
66.5
82.9
—
6
13
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
13
4.65
2.27
1.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
19
93
2.07
2.23
1.4
1.4
u/ml
203.5
255.4
0.69
13
48
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
9
5.59
2.21
2.4
1.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
9
5.59
2.21
1.0
1.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
48
2.53
2.19
1.8
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
48
2.53
2.19
1.8
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
8
24
3.36
2.18
1.3
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
193
1610
1.28
2.15
2.7
2.1
u/l
431.9
275.9
0.35
180
1511
(3037121) Protein [Mass/volume] in Urine
31
182
1.74
2.15
5.3
3.3
g/l
0.2
0.3
0.78
17
71
(3013512) EKG study
180
1489
1.29
2.14
5.2
3.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
27
456
0.58
2.14
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
49
2.48
2.11
1.8
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
49
2.48
2.11
1.8
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
49
2.48
2.11
1.8
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
20
103
1.97
2.07
1.5
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
35
546
0.62
2.04
1.7
2.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
44
2.52
2.02
1.8
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
38
2.66
2.01
1.2
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
31
496
0.61
2.01
1.6
2.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
126
1.85
2.00
1.6
1.4
ug/g
265.9
318.7
0.57
12
70
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
21
3.36
1.97
1.0
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
11
4.57
1.94
7.8
5.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
16
3.77
1.94
1.5
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
69
502
1.42
1.92
1.4
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
52
2.33
1.88
1.3
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
151
1813
0.78
1.88
2.9
2.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
20
107
1.90
1.88
2.4
2.0
u/l
12.6
4396.3
—
5
39
(3011397) Hemoglobin [Presence] in Urine by Test strip
146
1196
1.28
1.87
4.3
3.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
23
3.06
1.80
1.7
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
29
2.78
1.79
1.5
1.8
—
—
—
0
0
(3004451) EKG impression Narrative
7
24
2.94
1.72
1.0
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
13
3.87
1.72
1.4
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
13
3.87
1.72
1.4
1.0
%
74.4
85.8
—
5
13
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
116
1418
0.78
1.66
1.7
1.6
mmol/l
1.3
1.4
0.48
101
1184
(3051651) Icteric interference index of Serum or Plasma
7
25
2.82
1.65
2.0
2.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
12
56
2.16
1.62
1.7
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
244
2148
1.21
1.62
3.4
2.8
ug/l
337.1
118.6
1.49
227
1961
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
483
5097
0.81
1.60
4.6
4.6
mmol/l
6.0
6.0
0.03
430
4603
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
144
0.41
1.53
2.0
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
306
0.58
1.52
1.2
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
53
386
1.41
1.51
2.8
2.3
nmol/l
11.6
14.7
1.44
43
347
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
155
1.64
1.49
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
155
1.64
1.49
1.2
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
23
140
1.67
1.46
2.9
2.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
16
3.14
1.44
1.2
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
46
2.19
1.40
1.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
24
150
1.62
1.39
4.8
4.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
158
1.60
1.39
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
67
1.96
1.39
1.6
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
361
3330
1.18
1.36
3.5
3.0
u/l
55.4
43.7
2.10
341
3087
(3021960) Folate [Moles/volume] in Serum or Plasma
148
1261
1.22
1.34
1.7
1.5
nmol/l
19.6
21.0
0.56
133
1074
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
12
61
1.98
1.33
1.5
1.3
pmol/l
800.7
313.5
—
7
48
(3043410) Blood group antigens tested for on Red Blood Cells
5
18
2.79
1.28
2.2
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
24
154
1.58
1.27
1.4
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
150
1731
0.83
1.25
3.9
4.0
mg/mmol
7.1
8.3
0.26
96
1091
(3019309) Folate [Moles/volume] in Red Blood Cells
119
999
1.23
1.25
2.0
1.8
nmol/l
1341.0
1169.3
0.82
90
743
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
25
2.41
1.24
1.3
1.1
miu/ml
1813.8
1663.3
—
6
25
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
25
2.41
1.24
1.3
3.1
ug/l
61.1
85.2
—
6
25
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
577
5575
1.25
1.21
19.8
8.6
u/l
27.3
26.1
0.61
560
5336
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
12
64
1.89
1.18
1.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
34
0.00
1.16
0.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
24
158
1.54
1.16
3.3
1.7
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
13
72
1.82
1.15
2.0
1.4
pmol/l
134.5
60.5
0.61
13
72
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
35
0.00
1.15
0.0
1.1
—
9.2
—
0
6
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
8
40
2.01
1.12
1.5
1.3
mmol/l
2.2
1.9
—
8
40
(40761511) CBC panel - Blood by Automated count
566
5469
1.22
1.11
26.3
11.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
26
177
1.49
1.09
1.3
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
122
1043
1.21
1.08
3.5
3.9
ng/l
65.3
412.5
3.73
99
825
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
31
429
0.71
1.08
1.8
1.8
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
12
67
1.81
1.05
1.5
1.3
mu/l
41.6
62.4
0.33
12
58
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
22
2.28
1.03
1.6
2.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
419
3961
1.15
1.03
4.5
3.7
pmol/l
14.7
14.8
0.72
378
3573
(3023419) Bacteria identified in Sputum by Culture
12
68
1.78
1.01
3.8
2.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
35
2.01
1.00
1.4
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
76
1.72
0.99
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
22
148
1.50
0.99
1.2
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
62
1.79
0.94
1.5
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
27
2.23
0.93
1.0
1.1
iu/ml
183.3
144.3
—
6
27
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
22
313
0.69
0.91
1.0
1.2
iu/ml
111.8
140.3
—
6
118
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
94
1.61
0.91
1.1
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
6
29
2.08
0.89
2.2
1.6
u/field
0.5
4.7
—
6
20
(3022217) INR in Platelet poor plasma by Coagulation assay
83
698
1.22
0.89
20.4
26.8
inr
1.5
1.4
—
8
103
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
79
1.66
0.88
2.9
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
499
4801
1.15
0.88
31.8
13.7
%
37.0
40.1
10.67
332
3377
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
62
506
1.25
0.87
2.1
2.5
ug/l
4.5
7.3
1.80
57
443
(3051611) Lipemic interference index of Serum or Plasma
8
43
1.87
0.87
2.4
2.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
11
64
1.73
0.86
1.5
1.3
—
—
—
0
0
(4010399)
27
366
0.73
0.86
1.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
73
870
0.82
0.86
1.3
1.3
iu/ml
42.8
36.6
0.10
26
268
(4034850)
11
177
0.62
0.82
5.7
10.8
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
19
130
1.47
0.81
1.7
2.3
mg/l
10.7
12.2
0.30
19
119
(3012516) Albumin [Mass/volume] in Urine
146
1630
0.87
0.81
3.6
3.2
mg/l
2835.7
173.0
1.94
96
1035
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
70
830
0.83
0.79
1.2
1.3
u/ml
21.5
11.3
0.36
23
319
(3006653) Thiamine [Moles/volume] in Blood
0
28
0.00
0.76
0.0
1.6
—
159.6
—
0
28
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
255
0.70
0.76
1.7
2.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
205
1883
1.13
0.73
4.5
3.7
ug/l
4.8
1.9
0.66
183
1676
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
25
2.01
0.73
2.2
1.9
umol/l
34.2
30.2
—
5
25
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
17
117
1.46
0.72
1.2
1.2
mmol/l
3.7
3.9
0.43
17
110
(4281824)
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
58
1.56
0.70
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
204
0.68
0.69
1.6
1.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
20
145
1.39
0.66
1.5
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
270
0.73
0.65
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
163
1.36
0.65
1.6
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
12
79
1.53
0.63
1.0
1.1
—
17.9
—
0
6
(1002224) Polysomnography panel
16
222
0.71
0.62
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
96
1.47
0.62
1.6
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
8
51
1.58
0.60
2.3
3.5
nmol/l
21.3
25.9
—
8
46
(3036071) Salmonella sp Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.3
—
21.3
—
0
6
(3009508) Creatinine [Moles/volume] in Urine
165
1791
0.90
0.59
3.1
3.2
mmol/l
7.3
7.7
0.54
138
1502
(3013139) Helicobacter pylori Ag [Presence] in Stool
25
320
0.77
0.58
1.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
23
0.00
0.58
0.0
1.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
36
1.67
0.57
1.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
73
1.52
0.56
3.2
2.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
11
75
1.47
0.51
3.2
2.4
mmol/l
4.0
4.1
0.17
11
75
(3035285) Chloride [Moles/volume] in Venous blood
11
75
1.47
0.51
3.2
2.4
mmol/l
105.3
105.7
0.08
11
75
(3021387) Prolactin [Units/volume] in Serum or Plasma
18
136
1.33
0.49
1.4
1.6
mu/l
254.8
276.3
0.22
18
125
(3039443) Prostate specific Ag panel - Serum or Plasma
7
107
0.65
0.49
1.1
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
23
181
1.28
0.48
1.5
2.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
76
1.45
0.48
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
49
1.43
0.46
1.4
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
77
1.44
0.45
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
141
0.70
0.45
3.2
1.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
51
1.38
0.44
5.7
3.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
123
1132
1.11
0.44
2.0
1.7
pmol/l
464.4
14039311.9
0.79
100
926
(3019150) Specific gravity of Urine by Refractometry
128
1183
1.10
0.42
5.1
3.7
kg/l
1.0
1.0
0.01
21
182
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
131
1.31
0.42
1.4
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
229
2174
1.08
0.41
2.0
2.0
pmol/l
91.2
95.5
0.61
131
1109
(3006576) Bicarbonate [Moles/volume] in Blood
0
16
0.00
0.41
0.0
8.0
—
25.1
—
0
16
(3016879) Cocaine [Presence] in Urine
15
194
0.77
0.41
2.2
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
205
0.78
0.40
2.6
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
204
0.78
0.39
2.1
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
30
252
1.20
0.38
1.2
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
16
203
0.78
0.38
2.1
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
45
393
1.16
0.37
1.8
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
202
0.79
0.37
2.1
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
330
3187
1.07
0.37
2.9
3.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
81
1.36
0.36
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
76
0.66
0.36
1.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
13
100
1.31
0.33
4.4
3.9
mg/l
35.9
25.4
—
7
70
(3000330) Specific gravity of Urine by Test strip
32
275
1.17
0.33
3.9
3.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
187
0.80
0.32
1.5
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
23
193
1.20
0.31
1.6
1.8
—
—
—
0
0
(4268621)
7
55
1.28
0.30
2.3
2.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
56
1.25
0.29
1.3
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
184
0.81
0.29
1.2
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
62
1.29
0.28
1.1
1.4
nmol/l
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
52
471
1.11
0.27
3.7
3.1
ng/l
169.3
199.2
0.27
46
439
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
75
0.66
0.26
1.4
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
133
1.21
0.24
1.1
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
39
1.28
0.23
1.4
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
156
0.83
0.21
2.4
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
11
0.00
0.21
0.0
4.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
12
0.00
0.21
0.0
9.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
43
1.16
0.21
1.4
1.2
—
81.8
—
0
6
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
13
0.00
0.21
0.0
1.6
—
10.6
—
0
7
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(4133840)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
113
0.79
0.20
1.0
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
12
144
0.83
0.20
1.8
2.4
ug/min
59.1
93.1
—
6
84
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
122
0.82
0.19
1.5
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
592
5874
1.07
0.19
44.2
17.8
fl
91.0
90.8
0.56
585
5764
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
175
1.15
0.18
1.5
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
592
5875
1.07
0.18
44.1
17.8
pg
30.2
30.3
0.46
585
5765
(3004616) Nuclear Ab [Presence] in Serum
7
59
1.19
0.18
1.3
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
592
5876
1.06
0.18
44.3
17.8
e12/l
4.3
4.5
22.43
574
5671
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
110
1.19
0.17
1.9
1.5
—
—
—
0
0
(3000492) Spirometry study
50
466
1.08
0.17
1.4
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
592
5878
1.06
0.17
44.3
17.9
e9/l
6.8
6.7
0.32
575
5676
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
68
1.18
0.16
1.1
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
43
463
0.92
0.16
1.2
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
592
5879
1.06
0.16
44.6
18.0
g/l
127.7
136.9
32.54
585
5767
(3048689) Calprotectin [Mass/mass] in Stool
66
624
1.06
0.16
2.2
2.4
ug/g
113.3
112.5
0.01
52
483
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
8
73
1.10
0.15
1.1
1.1
%
115.8
120.1
—
8
67
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
121
1166
1.05
0.15
1.2
1.3
u/ml
1.4
2.2
0.62
34
307
(3003327) Ova and parasites identified in Stool by Light microscopy
18
160
1.13
0.14
1.2
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
58
612
0.94
0.13
1.6
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
71
677
1.05
0.13
1.3
1.3
titre
400.0
514.4
0.37
12
149
(3007461) Platelets [#/volume] in Blood
591
5875
1.05
0.13
44.5
17.9
e9/l
245.0
247.4
0.35
575
5691
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
46
1.09
0.09
1.0
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
47
1.06
0.09
1.2
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
116
1.12
0.09
1.5
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
54
1.11
0.09
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
113
0.88
0.08
1.7
2.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
74
1.08
0.07
1.1
1.4
nmol/l
0.5
0.6
—
8
68
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
8
74
1.08
0.07
1.1
1.4
nmol/l
—
0.6
—
0
8
(4094501)
13
143
0.91
0.07
1.3
1.1
—
—
—
0
0
(4306422)
8
76
1.05
0.07
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
42
438
0.96
0.07
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
87
1.03
0.07
1.2
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
90
879
1.03
0.06
1.3
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
482
4797
1.02
0.05
5.2
4.5
mu/l
1.9
1.9
0.12
437
4358
(3028707) Methadone [Presence] in Urine by Screen method
11
101
1.09
0.04
3.3
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
149
1507
0.99
0.04
4.2
3.6
%
23.4
23.9
0.15
67
683
(40768797) Stomach Pathology biopsy report
71
697
1.02
0.03
1.3
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
64
650
0.98
0.02
4.4
4.7
%
30.2
32.1
0.82
46
427
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
105
1057
0.99
0.01
2.7
2.6
ug/l
0.8
0.7
0.38
72
683
(3001019) Free T4 and TSH panel - Serum or Plasma
22
226
0.97
0.00
1.6
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
59
595
0.99
0.00
2.0
1.8
%
1.6
1.5
0.15
51
514
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
287
1.01
0.00
2.2
2.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
33
328
1.01
0.00
5.2
2.7
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
6.7
—
0
8
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(4146454)
6
59
1.02
0.00
1.5
2.6
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
1.2
—
0
5
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
81
0.99
0.00
1.1
1.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
7.8
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
7
77
0.91
0.00
1.1
1.1
—
4.2
—
0
20
(3052592) Norovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
3.3
—
7.7
—
0
6
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
79
0.88
0.00
1.1
1.8
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_BONE_CARTILAGE_EXALLC – Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).